SCHEMBL357110

SCHEMBL357110

[CH2]C(C)(N)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8185666 0.78
SCHEMBL263974 0.75
SCHEMBL11499984 0.74
SCHEMBL28020844 0.74 TSHR (0.35)
SCHEMBL27923834 0.74
SCHEMBL1725 0.73
SCHEMBL1398293 0.73
SCHEMBL155400 0.73
SCHEMBL4221722 0.73 TSHR (0.50)
SCHEMBL10975 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103987399-A Novel cyclosporin derivatives for the treatment and prevention of viral infections S & T GLOBAL INC 2014-08-13 CN claimed
CN-103249424-A Novel cyclosporin derivatives for the treatment and prevention of a viral infection S & T GLOBAL INC 2013-08-14 CN claimed
CN-103153329-A Use of novel cyclosporin A derivatives for the treatment and prevention of viral infections S & T GLOBAL INC 2013-06-12 CN claimed
CN-101505971-A Cast-coating-like inkjet printing material M REAL OYJ (FI) 2009-08-12 CN claimed
US-5458885-A Transdermal drug delivery device LTS LOHMANN THERAPIE-SYSTEME GMBH & CO., KG OF GERMANY (DE) 1995-10-17 US claimed
CN-113631538-B Novel potassium channel inhibitors 萨尼奥纳有限责任公司 2024-05-31 CN disclosed
US-20210088524-A1 IMAGING AGENT UNIVERSITY OF LANCASTER (GB) 2021-03-25 US disclosed
US-10201525-B2 Tetrazole-substituted arylamides as PX2 and PX2/3 antagonists ROCHE PALO ALTO LLC (US) 2019-02-12 US disclosed
WO-2018185493-A1 IMAGING AGENT UNIVERSITY OF LANCASTER (GB) 2018-10-11 WO disclosed
US-20180199575-A1 SUBSTITUTED OXOTETRAHYDROQUINOLINYLPHOSPHINIC ACID AND PHOSPHINIC ACID AMIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-07-19 US disclosed
EP-3322296-A1 SUBSTITUTED OXO-TETRAHYDROQUINOLINYL-PHOSPHINIC ACID AND PHOSPHINIC ACID AMIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS Bayer CropScience Aktiengesellschaft (DE) 2018-05-23 EP disclosed
US-20170143672-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDES AS PX2 AND PX2/3 ANTAGONISTS ROCHE PALO ALTO LLC (US) 2017-05-25 US disclosed
WO-2005080360-A1 COMPOUNDS ASTRAZENECA AB (SE) 2005-09-01 WO disclosed
WO-2005080359-A1 BENZAMIDE DERIVATIVES AND THEIR USE AS GLUCOKINAE ACTIVATING AGENTS ASTRAZENECA AB (SE) 2005-09-01 WO disclosed
CN-1538972-A Adenosine A3 receptor agonists CVҽҩ���޹�˾ 2004-10-20 CN disclosed
CN-1533388-A Substituted piperazine compounds and their use as fatty acid oxidation inhibitors CVҽҩ���޹�˾ 2004-09-29 CN disclosed
EP-1370421-A1 SHEENY INK JET PRINTING MATERIAL M-real Zanders GmbH (DE) 2003-12-17 EP disclosed
WO-2002072359-A1 SHEENY INK JET PRINTING MATERIAL ZANDERS FEINPAPIERE AG (DE) 2002-09-19 WO disclosed
EP-1146061-A1 MICHAEL ADDITION TYPE URETHANE-UREA RESIN, PROCESS FOR PRODUCING THE SAME, PRESSURE-SENSITIVE ADHESIVE, PROCESS FOR PRODUCING THE SAME, COATING MATERIAL FOR FORMING INK-RECEIVING LAYER, AND RECORDING MATERIAL Toyo Ink Manufacturing Co. Ltd. (JP) 2001-10-17 EP disclosed
US-5458885-A Transdermal drug delivery device LTS LOHMANN THERAPIE-SYSTEME GMBH & CO., KG OF GERMANY (DE) 1995-10-17 US disclosed